nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—PDE3A—Anagrelide—hematologic cancer	0.692	1	CbGbCtD
Levosimendan—TNNC1—hematopoietic system—hematologic cancer	0.00691	0.141	CbGeAlD
Levosimendan—TNNC1—blood—hematologic cancer	0.00458	0.0933	CbGeAlD
Levosimendan—KCNJ11—hematopoietic system—hematologic cancer	0.00422	0.0861	CbGeAlD
Levosimendan—PDE3A—hematopoietic system—hematologic cancer	0.00414	0.0844	CbGeAlD
Levosimendan—TNNC1—lung—hematologic cancer	0.00401	0.0818	CbGeAlD
Levosimendan—TNNC1—testis—hematologic cancer	0.00378	0.0772	CbGeAlD
Levosimendan—KCNJ8—lung—hematologic cancer	0.00301	0.0614	CbGeAlD
Levosimendan—KCNJ8—testis—hematologic cancer	0.00284	0.0579	CbGeAlD
Levosimendan—TNNC1—lymph node—hematologic cancer	0.00274	0.056	CbGeAlD
Levosimendan—PDE3A—blood—hematologic cancer	0.00274	0.0559	CbGeAlD
Levosimendan—PDE3A—lung—hematologic cancer	0.0024	0.049	CbGeAlD
Levosimendan—PDE3A—testis—hematologic cancer	0.00227	0.0462	CbGeAlD
Levosimendan—KCNJ8—lymph node—hematologic cancer	0.00206	0.042	CbGeAlD
Levosimendan—KCNJ11—lymph node—hematologic cancer	0.00168	0.0342	CbGeAlD
Levosimendan—PDE3A—lymph node—hematologic cancer	0.00164	0.0335	CbGeAlD
Levosimendan—Vomiting—Bexarotene—hematologic cancer	0.000275	0.00126	CcSEcCtD
Levosimendan—Vomiting—Fludarabine—hematologic cancer	0.000274	0.00125	CcSEcCtD
Levosimendan—Diarrhoea—Nilotinib—hematologic cancer	0.000273	0.00125	CcSEcCtD
Levosimendan—Angiopathy—Etoposide—hematologic cancer	0.000272	0.00125	CcSEcCtD
Levosimendan—Constipation—Bortezomib—hematologic cancer	0.000272	0.00125	CcSEcCtD
Levosimendan—Diarrhoea—Imatinib—hematologic cancer	0.000272	0.00124	CcSEcCtD
Levosimendan—Headache—Bexarotene—hematologic cancer	0.000271	0.00124	CcSEcCtD
Levosimendan—Headache—Dasatinib—hematologic cancer	0.000271	0.00124	CcSEcCtD
Levosimendan—Headache—Fludarabine—hematologic cancer	0.00027	0.00124	CcSEcCtD
Levosimendan—Nausea—Busulfan—hematologic cancer	0.00027	0.00124	CcSEcCtD
Levosimendan—Tachycardia—Carmustine—hematologic cancer	0.000269	0.00123	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Vinorelbine—hematologic cancer	0.000268	0.00123	CcSEcCtD
Levosimendan—Hypotension—Thalidomide—hematologic cancer	0.000268	0.00123	CcSEcCtD
Levosimendan—Nervous system disorder—Alitretinoin—hematologic cancer	0.000268	0.00123	CcSEcCtD
Levosimendan—Diarrhoea—Cladribine—hematologic cancer	0.000267	0.00122	CcSEcCtD
Levosimendan—Tachycardia—Alitretinoin—hematologic cancer	0.000267	0.00122	CcSEcCtD
Levosimendan—Constipation—Vinorelbine—hematologic cancer	0.000266	0.00122	CcSEcCtD
Levosimendan—Nervous system disorder—Ifosfamide—hematologic cancer	0.000265	0.00121	CcSEcCtD
Levosimendan—Dizziness—Nilotinib—hematologic cancer	0.000264	0.00121	CcSEcCtD
Levosimendan—Dizziness—Imatinib—hematologic cancer	0.000263	0.0012	CcSEcCtD
Levosimendan—Nausea—Procarbazine—hematologic cancer	0.000262	0.0012	CcSEcCtD
Levosimendan—Insomnia—Thalidomide—hematologic cancer	0.00026	0.00119	CcSEcCtD
Levosimendan—Vomiting—Chlorambucil—hematologic cancer	0.00026	0.00119	CcSEcCtD
Levosimendan—Nervous system disorder—Vincristine—hematologic cancer	0.000258	0.00118	CcSEcCtD
Levosimendan—Dizziness—Cladribine—hematologic cancer	0.000258	0.00118	CcSEcCtD
Levosimendan—Hypotension—Carmustine—hematologic cancer	0.000258	0.00118	CcSEcCtD
Levosimendan—Nausea—Dasatinib—hematologic cancer	0.000257	0.00118	CcSEcCtD
Levosimendan—Nausea—Bexarotene—hematologic cancer	0.000257	0.00118	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.000256	0.00117	CcSEcCtD
Levosimendan—Nausea—Fludarabine—hematologic cancer	0.000256	0.00117	CcSEcCtD
Levosimendan—Diarrhoea—Vinblastine—hematologic cancer	0.000256	0.00117	CcSEcCtD
Levosimendan—Hypotension—Alitretinoin—hematologic cancer	0.000255	0.00117	CcSEcCtD
Levosimendan—Constipation—Thiotepa—hematologic cancer	0.000254	0.00116	CcSEcCtD
Levosimendan—Vomiting—Nilotinib—hematologic cancer	0.000254	0.00116	CcSEcCtD
Levosimendan—Vomiting—Imatinib—hematologic cancer	0.000252	0.00116	CcSEcCtD
Levosimendan—Hypotension—Ifosfamide—hematologic cancer	0.000252	0.00116	CcSEcCtD
Levosimendan—Nervous system disorder—Irinotecan—hematologic cancer	0.000252	0.00115	CcSEcCtD
Levosimendan—Tachycardia—Mitoxantrone—hematologic cancer	0.00025	0.00115	CcSEcCtD
Levosimendan—Headache—Nilotinib—hematologic cancer	0.00025	0.00115	CcSEcCtD
Levosimendan—Insomnia—Carmustine—hematologic cancer	0.00025	0.00114	CcSEcCtD
Levosimendan—Cardiac failure—Epirubicin—hematologic cancer	0.000249	0.00114	CcSEcCtD
Levosimendan—Headache—Imatinib—hematologic cancer	0.000249	0.00114	CcSEcCtD
Levosimendan—Vomiting—Cladribine—hematologic cancer	0.000248	0.00114	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000248	0.00114	CcSEcCtD
Levosimendan—Dizziness—Vinblastine—hematologic cancer	0.000247	0.00113	CcSEcCtD
Levosimendan—Insomnia—Alitretinoin—hematologic cancer	0.000247	0.00113	CcSEcCtD
Levosimendan—Hypotension—Vincristine—hematologic cancer	0.000246	0.00113	CcSEcCtD
Levosimendan—Constipation—Thalidomide—hematologic cancer	0.000246	0.00112	CcSEcCtD
Levosimendan—Nervous system disorder—Gemcitabine—hematologic cancer	0.000245	0.00112	CcSEcCtD
Levosimendan—Headache—Cladribine—hematologic cancer	0.000244	0.00112	CcSEcCtD
Levosimendan—Diarrhoea—Melphalan—hematologic cancer	0.000244	0.00111	CcSEcCtD
Levosimendan—Nausea—Chlorambucil—hematologic cancer	0.000243	0.00111	CcSEcCtD
Levosimendan—Hypotension—Mitoxantrone—hematologic cancer	0.00024	0.0011	CcSEcCtD
Levosimendan—Hypotension—Irinotecan—hematologic cancer	0.00024	0.0011	CcSEcCtD
Levosimendan—Insomnia—Vincristine—hematologic cancer	0.000238	0.00109	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000238	0.00109	CcSEcCtD
Levosimendan—Vomiting—Vinblastine—hematologic cancer	0.000238	0.00109	CcSEcCtD
Levosimendan—Nausea—Nilotinib—hematologic cancer	0.000237	0.00109	CcSEcCtD
Levosimendan—Diarrhoea—Lenalidomide—hematologic cancer	0.000237	0.00108	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000236	0.00108	CcSEcCtD
Levosimendan—Constipation—Carmustine—hematologic cancer	0.000236	0.00108	CcSEcCtD
Levosimendan—Nausea—Imatinib—hematologic cancer	0.000236	0.00108	CcSEcCtD
Levosimendan—Headache—Vinblastine—hematologic cancer	0.000234	0.00107	CcSEcCtD
Levosimendan—Constipation—Alitretinoin—hematologic cancer	0.000234	0.00107	CcSEcCtD
Levosimendan—Diarrhoea—Hydroxyurea—hematologic cancer	0.000233	0.00107	CcSEcCtD
Levosimendan—Hypotension—Gemcitabine—hematologic cancer	0.000233	0.00107	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000233	0.00107	CcSEcCtD
Levosimendan—Insomnia—Irinotecan—hematologic cancer	0.000232	0.00106	CcSEcCtD
Levosimendan—Nausea—Cladribine—hematologic cancer	0.000232	0.00106	CcSEcCtD
Levosimendan—Constipation—Ifosfamide—hematologic cancer	0.000231	0.00106	CcSEcCtD
Levosimendan—Cardiac failure—Doxorubicin—hematologic cancer	0.000231	0.00106	CcSEcCtD
Levosimendan—Dizziness—Lenalidomide—hematologic cancer	0.000229	0.00105	CcSEcCtD
Levosimendan—Nervous system disorder—Cisplatin—hematologic cancer	0.000228	0.00105	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000227	0.00104	CcSEcCtD
Levosimendan—Tachycardia—Cisplatin—hematologic cancer	0.000227	0.00104	CcSEcCtD
Levosimendan—Vomiting—Melphalan—hematologic cancer	0.000226	0.00104	CcSEcCtD
Levosimendan—Insomnia—Gemcitabine—hematologic cancer	0.000226	0.00103	CcSEcCtD
Levosimendan—Dizziness—Hydroxyurea—hematologic cancer	0.000226	0.00103	CcSEcCtD
Levosimendan—Constipation—Vincristine—hematologic cancer	0.000225	0.00103	CcSEcCtD
Levosimendan—Angiopathy—Betamethasone—hematologic cancer	0.000224	0.00103	CcSEcCtD
Levosimendan—Angiopathy—Dexamethasone—hematologic cancer	0.000224	0.00103	CcSEcCtD
Levosimendan—Nausea—Vinblastine—hematologic cancer	0.000222	0.00102	CcSEcCtD
Levosimendan—Hypokalaemia—Epirubicin—hematologic cancer	0.000221	0.00101	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000221	0.00101	CcSEcCtD
Levosimendan—Vomiting—Lenalidomide—hematologic cancer	0.00022	0.00101	CcSEcCtD
Levosimendan—Constipation—Irinotecan—hematologic cancer	0.000219	0.001	CcSEcCtD
Levosimendan—Constipation—Mitoxantrone—hematologic cancer	0.000219	0.001	CcSEcCtD
Levosimendan—Diarrhoea—Bortezomib—hematologic cancer	0.000218	0.000998	CcSEcCtD
Levosimendan—Hypotension—Cisplatin—hematologic cancer	0.000218	0.000996	CcSEcCtD
Levosimendan—Vomiting—Hydroxyurea—hematologic cancer	0.000217	0.000993	CcSEcCtD
Levosimendan—Headache—Lenalidomide—hematologic cancer	0.000217	0.000993	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000216	0.000987	CcSEcCtD
Levosimendan—Headache—Hydroxyurea—hematologic cancer	0.000214	0.000979	CcSEcCtD
Levosimendan—Constipation—Gemcitabine—hematologic cancer	0.000214	0.000978	CcSEcCtD
Levosimendan—Diarrhoea—Vinorelbine—hematologic cancer	0.000213	0.000974	CcSEcCtD
Levosimendan—Nausea—Melphalan—hematologic cancer	0.000211	0.000968	CcSEcCtD
Levosimendan—Dizziness—Bortezomib—hematologic cancer	0.000211	0.000964	CcSEcCtD
Levosimendan—Tachycardia—Etoposide—hematologic cancer	0.000208	0.000953	CcSEcCtD
Levosimendan—Dizziness—Vinorelbine—hematologic cancer	0.000206	0.000941	CcSEcCtD
Levosimendan—Nausea—Lenalidomide—hematologic cancer	0.000206	0.000941	CcSEcCtD
Levosimendan—Tachycardia—Prednisolone—hematologic cancer	0.000205	0.00094	CcSEcCtD
Levosimendan—Hypokalaemia—Doxorubicin—hematologic cancer	0.000205	0.000938	CcSEcCtD
Levosimendan—Diarrhoea—Thiotepa—hematologic cancer	0.000203	0.00093	CcSEcCtD
Levosimendan—Nausea—Hydroxyurea—hematologic cancer	0.000203	0.000928	CcSEcCtD
Levosimendan—Vomiting—Bortezomib—hematologic cancer	0.000203	0.000927	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000201	0.00092	CcSEcCtD
Levosimendan—Vomiting—Bleomycin—hematologic cancer	0.000201	0.00092	CcSEcCtD
Levosimendan—Headache—Bortezomib—hematologic cancer	0.0002	0.000913	CcSEcCtD
Levosimendan—Hypotension—Etoposide—hematologic cancer	0.000199	0.000912	CcSEcCtD
Levosimendan—Vomiting—Vinorelbine—hematologic cancer	0.000198	0.000905	CcSEcCtD
Levosimendan—Diarrhoea—Thalidomide—hematologic cancer	0.000197	0.0009	CcSEcCtD
Levosimendan—Dizziness—Thiotepa—hematologic cancer	0.000196	0.000899	CcSEcCtD
Levosimendan—Angiopathy—Prednisone—hematologic cancer	0.000195	0.000894	CcSEcCtD
Levosimendan—Headache—Vinorelbine—hematologic cancer	0.000195	0.000892	CcSEcCtD
Levosimendan—Insomnia—Prednisolone—hematologic cancer	0.00019	0.000871	CcSEcCtD
Levosimendan—Dizziness—Thalidomide—hematologic cancer	0.00019	0.000869	CcSEcCtD
Levosimendan—Nausea—Bortezomib—hematologic cancer	0.000189	0.000866	CcSEcCtD
Levosimendan—Tachycardia—Triamcinolone—hematologic cancer	0.000189	0.000864	CcSEcCtD
Levosimendan—Vomiting—Thiotepa—hematologic cancer	0.000189	0.000864	CcSEcCtD
Levosimendan—Diarrhoea—Carmustine—hematologic cancer	0.000189	0.000864	CcSEcCtD
Levosimendan—Mental disorder—Prednisone—hematologic cancer	0.000189	0.000863	CcSEcCtD
Levosimendan—Nausea—Bleomycin—hematologic cancer	0.000188	0.000859	CcSEcCtD
Levosimendan—Malnutrition—Prednisone—hematologic cancer	0.000187	0.000858	CcSEcCtD
Levosimendan—Diarrhoea—Alitretinoin—hematologic cancer	0.000187	0.000856	CcSEcCtD
Levosimendan—Headache—Thiotepa—hematologic cancer	0.000186	0.000852	CcSEcCtD
Levosimendan—Diarrhoea—Ifosfamide—hematologic cancer	0.000185	0.000846	CcSEcCtD
Levosimendan—Nausea—Vinorelbine—hematologic cancer	0.000185	0.000846	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000184	0.000843	CcSEcCtD
Levosimendan—Vomiting—Thalidomide—hematologic cancer	0.000183	0.000836	CcSEcCtD
Levosimendan—Dizziness—Carmustine—hematologic cancer	0.000182	0.000835	CcSEcCtD
Levosimendan—Constipation—Etoposide—hematologic cancer	0.000182	0.000835	CcSEcCtD
Levosimendan—Dizziness—Alitretinoin—hematologic cancer	0.000181	0.000827	CcSEcCtD
Levosimendan—Diarrhoea—Vincristine—hematologic cancer	0.00018	0.000825	CcSEcCtD
Levosimendan—Headache—Thalidomide—hematologic cancer	0.00018	0.000824	CcSEcCtD
Levosimendan—Dizziness—Ifosfamide—hematologic cancer	0.000179	0.000818	CcSEcCtD
Levosimendan—Nausea—Thiotepa—hematologic cancer	0.000176	0.000808	CcSEcCtD
Levosimendan—Diarrhoea—Irinotecan—hematologic cancer	0.000175	0.000803	CcSEcCtD
Levosimendan—Diarrhoea—Mitoxantrone—hematologic cancer	0.000175	0.000803	CcSEcCtD
Levosimendan—Vomiting—Carmustine—hematologic cancer	0.000175	0.000803	CcSEcCtD
Levosimendan—Insomnia—Triamcinolone—hematologic cancer	0.000175	0.000801	CcSEcCtD
Levosimendan—Dizziness—Vincristine—hematologic cancer	0.000174	0.000797	CcSEcCtD
Levosimendan—Vomiting—Alitretinoin—hematologic cancer	0.000174	0.000795	CcSEcCtD
Levosimendan—Headache—Carmustine—hematologic cancer	0.000173	0.000791	CcSEcCtD
Levosimendan—Nervous system disorder—Dexamethasone—hematologic cancer	0.000172	0.000788	CcSEcCtD
Levosimendan—Nervous system disorder—Betamethasone—hematologic cancer	0.000172	0.000788	CcSEcCtD
Levosimendan—Vomiting—Ifosfamide—hematologic cancer	0.000172	0.000786	CcSEcCtD
Levosimendan—Tachycardia—Dexamethasone—hematologic cancer	0.000171	0.000784	CcSEcCtD
Levosimendan—Tachycardia—Betamethasone—hematologic cancer	0.000171	0.000784	CcSEcCtD
Levosimendan—Headache—Alitretinoin—hematologic cancer	0.000171	0.000784	CcSEcCtD
Levosimendan—Diarrhoea—Gemcitabine—hematologic cancer	0.000171	0.000782	CcSEcCtD
Levosimendan—Nausea—Thalidomide—hematologic cancer	0.000171	0.000781	CcSEcCtD
Levosimendan—Dizziness—Irinotecan—hematologic cancer	0.00017	0.000776	CcSEcCtD
Levosimendan—Vomiting—Vincristine—hematologic cancer	0.000167	0.000766	CcSEcCtD
Levosimendan—Cardiac disorder—Methotrexate—hematologic cancer	0.000167	0.000764	CcSEcCtD
Levosimendan—Headache—Vincristine—hematologic cancer	0.000165	0.000755	CcSEcCtD
Levosimendan—Hypotension—Dexamethasone—hematologic cancer	0.000164	0.000751	CcSEcCtD
Levosimendan—Hypotension—Betamethasone—hematologic cancer	0.000164	0.000751	CcSEcCtD
Levosimendan—Nausea—Carmustine—hematologic cancer	0.000164	0.00075	CcSEcCtD
Levosimendan—Angiopathy—Methotrexate—hematologic cancer	0.000163	0.000747	CcSEcCtD
Levosimendan—Vomiting—Mitoxantrone—hematologic cancer	0.000163	0.000746	CcSEcCtD
Levosimendan—Vomiting—Irinotecan—hematologic cancer	0.000163	0.000746	CcSEcCtD
Levosimendan—Nausea—Alitretinoin—hematologic cancer	0.000162	0.000743	CcSEcCtD
Levosimendan—Headache—Irinotecan—hematologic cancer	0.000161	0.000735	CcSEcCtD
Levosimendan—Headache—Mitoxantrone—hematologic cancer	0.000161	0.000735	CcSEcCtD
Levosimendan—Nausea—Ifosfamide—hematologic cancer	0.00016	0.000734	CcSEcCtD
Levosimendan—Diarrhoea—Cisplatin—hematologic cancer	0.000159	0.000729	CcSEcCtD
Levosimendan—Vomiting—Gemcitabine—hematologic cancer	0.000159	0.000727	CcSEcCtD
Levosimendan—Insomnia—Betamethasone—hematologic cancer	0.000159	0.000727	CcSEcCtD
Levosimendan—Insomnia—Dexamethasone—hematologic cancer	0.000159	0.000727	CcSEcCtD
Levosimendan—Mental disorder—Methotrexate—hematologic cancer	0.000158	0.000721	CcSEcCtD
Levosimendan—Malnutrition—Methotrexate—hematologic cancer	0.000157	0.000717	CcSEcCtD
Levosimendan—Headache—Gemcitabine—hematologic cancer	0.000157	0.000716	CcSEcCtD
Levosimendan—Nausea—Vincristine—hematologic cancer	0.000156	0.000716	CcSEcCtD
Levosimendan—Cardiac disorder—Epirubicin—hematologic cancer	0.000156	0.000715	CcSEcCtD
Levosimendan—Angiopathy—Epirubicin—hematologic cancer	0.000153	0.000699	CcSEcCtD
Levosimendan—Nausea—Irinotecan—hematologic cancer	0.000152	0.000697	CcSEcCtD
Levosimendan—Nausea—Mitoxantrone—hematologic cancer	0.000152	0.000697	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000152	0.000694	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000152	0.000694	CcSEcCtD
Levosimendan—Nervous system disorder—Prednisone—hematologic cancer	0.00015	0.000686	CcSEcCtD
Levosimendan—Tachycardia—Prednisone—hematologic cancer	0.000149	0.000683	CcSEcCtD
Levosimendan—Nausea—Gemcitabine—hematologic cancer	0.000148	0.000679	CcSEcCtD
Levosimendan—Vomiting—Cisplatin—hematologic cancer	0.000148	0.000678	CcSEcCtD
Levosimendan—Mental disorder—Epirubicin—hematologic cancer	0.000147	0.000675	CcSEcCtD
Levosimendan—Malnutrition—Epirubicin—hematologic cancer	0.000147	0.000671	CcSEcCtD
Levosimendan—Diarrhoea—Etoposide—hematologic cancer	0.000146	0.000668	CcSEcCtD
Levosimendan—Cardiac disorder—Doxorubicin—hematologic cancer	0.000145	0.000662	CcSEcCtD
Levosimendan—Angiopathy—Doxorubicin—hematologic cancer	0.000141	0.000647	CcSEcCtD
Levosimendan—Dizziness—Etoposide—hematologic cancer	0.000141	0.000646	CcSEcCtD
Levosimendan—Dizziness—Prednisolone—hematologic cancer	0.000139	0.000637	CcSEcCtD
Levosimendan—Nausea—Cisplatin—hematologic cancer	0.000138	0.000633	CcSEcCtD
Levosimendan—Insomnia—Prednisone—hematologic cancer	0.000138	0.000633	CcSEcCtD
Levosimendan—Mental disorder—Doxorubicin—hematologic cancer	0.000136	0.000625	CcSEcCtD
Levosimendan—Vomiting—Etoposide—hematologic cancer	0.000136	0.000621	CcSEcCtD
Levosimendan—Malnutrition—Doxorubicin—hematologic cancer	0.000136	0.000621	CcSEcCtD
Levosimendan—Headache—Etoposide—hematologic cancer	0.000134	0.000612	CcSEcCtD
Levosimendan—Headache—Prednisolone—hematologic cancer	0.000132	0.000603	CcSEcCtD
Levosimendan—Constipation—Prednisone—hematologic cancer	0.000131	0.000599	CcSEcCtD
Levosimendan—Dizziness—Triamcinolone—hematologic cancer	0.000128	0.000586	CcSEcCtD
Levosimendan—Nausea—Etoposide—hematologic cancer	0.000127	0.00058	CcSEcCtD
Levosimendan—Nervous system disorder—Methotrexate—hematologic cancer	0.000125	0.000574	CcSEcCtD
Levosimendan—Nausea—Prednisolone—hematologic cancer	0.000125	0.000572	CcSEcCtD
Levosimendan—Vomiting—Triamcinolone—hematologic cancer	0.000123	0.000563	CcSEcCtD
Levosimendan—Headache—Triamcinolone—hematologic cancer	0.000121	0.000555	CcSEcCtD
Levosimendan—Diarrhoea—Dexamethasone—hematologic cancer	0.00012	0.00055	CcSEcCtD
Levosimendan—Diarrhoea—Betamethasone—hematologic cancer	0.00012	0.00055	CcSEcCtD
Levosimendan—Hypotension—Methotrexate—hematologic cancer	0.000119	0.000547	CcSEcCtD
Levosimendan—Nervous system disorder—Epirubicin—hematologic cancer	0.000117	0.000537	CcSEcCtD
Levosimendan—Tachycardia—Epirubicin—hematologic cancer	0.000117	0.000534	CcSEcCtD
Levosimendan—Dizziness—Dexamethasone—hematologic cancer	0.000116	0.000531	CcSEcCtD
Levosimendan—Dizziness—Betamethasone—hematologic cancer	0.000116	0.000531	CcSEcCtD
Levosimendan—Insomnia—Methotrexate—hematologic cancer	0.000116	0.000529	CcSEcCtD
Levosimendan—Nausea—Triamcinolone—hematologic cancer	0.000115	0.000526	CcSEcCtD
Levosimendan—Hypotension—Epirubicin—hematologic cancer	0.000112	0.000511	CcSEcCtD
Levosimendan—Vomiting—Dexamethasone—hematologic cancer	0.000112	0.000511	CcSEcCtD
Levosimendan—Vomiting—Betamethasone—hematologic cancer	0.000112	0.000511	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.00011	0.000505	CcSEcCtD
Levosimendan—Headache—Dexamethasone—hematologic cancer	0.00011	0.000503	CcSEcCtD
Levosimendan—Headache—Betamethasone—hematologic cancer	0.00011	0.000503	CcSEcCtD
Levosimendan—Nervous system disorder—Doxorubicin—hematologic cancer	0.000109	0.000497	CcSEcCtD
Levosimendan—Insomnia—Epirubicin—hematologic cancer	0.000108	0.000495	CcSEcCtD
Levosimendan—Tachycardia—Doxorubicin—hematologic cancer	0.000108	0.000494	CcSEcCtD
Levosimendan—Diarrhoea—Prednisone—hematologic cancer	0.000105	0.000479	CcSEcCtD
Levosimendan—Nausea—Dexamethasone—hematologic cancer	0.000104	0.000477	CcSEcCtD
Levosimendan—Nausea—Betamethasone—hematologic cancer	0.000104	0.000477	CcSEcCtD
Levosimendan—Hypotension—Doxorubicin—hematologic cancer	0.000103	0.000473	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000103	0.000473	CcSEcCtD
Levosimendan—Constipation—Epirubicin—hematologic cancer	0.000102	0.000468	CcSEcCtD
Levosimendan—Dizziness—Prednisone—hematologic cancer	0.000101	0.000463	CcSEcCtD
Levosimendan—Insomnia—Doxorubicin—hematologic cancer	0.0001	0.000458	CcSEcCtD
Levosimendan—Vomiting—Prednisone—hematologic cancer	9.72e-05	0.000445	CcSEcCtD
Levosimendan—Headache—Prednisone—hematologic cancer	9.58e-05	0.000438	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.55e-05	0.000437	CcSEcCtD
Levosimendan—Constipation—Doxorubicin—hematologic cancer	9.46e-05	0.000433	CcSEcCtD
Levosimendan—Nausea—Prednisone—hematologic cancer	9.08e-05	0.000416	CcSEcCtD
Levosimendan—Diarrhoea—Methotrexate—hematologic cancer	8.74e-05	0.0004	CcSEcCtD
Levosimendan—Dizziness—Methotrexate—hematologic cancer	8.45e-05	0.000387	CcSEcCtD
Levosimendan—Diarrhoea—Epirubicin—hematologic cancer	8.18e-05	0.000375	CcSEcCtD
Levosimendan—Vomiting—Methotrexate—hematologic cancer	8.12e-05	0.000372	CcSEcCtD
Levosimendan—Headache—Methotrexate—hematologic cancer	8.01e-05	0.000366	CcSEcCtD
Levosimendan—Dizziness—Epirubicin—hematologic cancer	7.91e-05	0.000362	CcSEcCtD
Levosimendan—Vomiting—Epirubicin—hematologic cancer	7.6e-05	0.000348	CcSEcCtD
Levosimendan—Nausea—Methotrexate—hematologic cancer	7.59e-05	0.000347	CcSEcCtD
Levosimendan—Diarrhoea—Doxorubicin—hematologic cancer	7.57e-05	0.000347	CcSEcCtD
Levosimendan—Headache—Epirubicin—hematologic cancer	7.49e-05	0.000343	CcSEcCtD
Levosimendan—Dizziness—Doxorubicin—hematologic cancer	7.32e-05	0.000335	CcSEcCtD
Levosimendan—Nausea—Epirubicin—hematologic cancer	7.1e-05	0.000325	CcSEcCtD
Levosimendan—Vomiting—Doxorubicin—hematologic cancer	7.04e-05	0.000322	CcSEcCtD
Levosimendan—Headache—Doxorubicin—hematologic cancer	6.93e-05	0.000317	CcSEcCtD
Levosimendan—Nausea—Doxorubicin—hematologic cancer	6.57e-05	0.000301	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—CNR2—hematologic cancer	5.87e-05	0.00146	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTAP—hematologic cancer	5.85e-05	0.00145	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RAC2—hematologic cancer	5.77e-05	0.00143	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CREB1—hematologic cancer	5.72e-05	0.00142	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HGF—hematologic cancer	5.66e-05	0.00141	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—BRAF—hematologic cancer	5.65e-05	0.0014	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CSF2—hematologic cancer	5.6e-05	0.00139	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ARHGEF12—hematologic cancer	5.52e-05	0.00137	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADCY7—hematologic cancer	5.52e-05	0.00137	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTHLH—hematologic cancer	5.49e-05	0.00136	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—HRAS—hematologic cancer	5.48e-05	0.00136	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PRKCG—hematologic cancer	5.41e-05	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—JAK1—hematologic cancer	5.41e-05	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ARHGEF1—hematologic cancer	5.38e-05	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTGER4—hematologic cancer	5.35e-05	0.00133	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—FHL2—hematologic cancer	5.22e-05	0.0013	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AGRN—hematologic cancer	5.12e-05	0.00127	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2RA—hematologic cancer	5.05e-05	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCL3—hematologic cancer	5.04e-05	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTHLH—hematologic cancer	4.99e-05	0.00124	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PDGFB—hematologic cancer	4.87e-05	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTGER4—hematologic cancer	4.86e-05	0.00121	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—IDH2—hematologic cancer	4.85e-05	0.00121	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMMR—hematologic cancer	4.85e-05	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL17—hematologic cancer	4.82e-05	0.0012	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGRN—hematologic cancer	4.82e-05	0.0012	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR5—hematologic cancer	4.73e-05	0.00118	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MDM2—hematologic cancer	4.73e-05	0.00118	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CDK2—hematologic cancer	4.73e-05	0.00117	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCR4—hematologic cancer	4.72e-05	0.00117	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEF1—hematologic cancer	4.65e-05	0.00116	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNA13—hematologic cancer	4.57e-05	0.00114	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ARNTL—hematologic cancer	4.56e-05	0.00113	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL3—hematologic cancer	4.55e-05	0.00113	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK14—hematologic cancer	4.54e-05	0.00113	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TIAM1—hematologic cancer	4.5e-05	0.00112	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ACP5—hematologic cancer	4.44e-05	0.0011	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CA9—hematologic cancer	4.44e-05	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—RASGRP1—hematologic cancer	4.41e-05	0.00109	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FN1—hematologic cancer	4.39e-05	0.00109	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOR2—hematologic cancer	4.38e-05	0.00109	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAK3—hematologic cancer	4.36e-05	0.00108	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCR4—hematologic cancer	4.29e-05	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CG—hematologic cancer	4.21e-05	0.00105	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL13—hematologic cancer	4.18e-05	0.00104	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCR7—hematologic cancer	4.18e-05	0.00104	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—IDH1—hematologic cancer	4.17e-05	0.00104	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL3—hematologic cancer	4.14e-05	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PTPN11—hematologic cancer	4.13e-05	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NCOR2—hematologic cancer	4.13e-05	0.00103	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCC3—hematologic cancer	4.12e-05	0.00102	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTO1—hematologic cancer	4.12e-05	0.00102	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TXN—hematologic cancer	4.12e-05	0.00102	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL3RA—hematologic cancer	4.08e-05	0.00101	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CRKL—hematologic cancer	4.08e-05	0.00101	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SPHK1—hematologic cancer	4.04e-05	0.001	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RASGRP1—hematologic cancer	4e-05	0.000994	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GRB2—hematologic cancer	3.96e-05	0.000984	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RGS2—hematologic cancer	3.93e-05	0.000977	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CREBBP—hematologic cancer	3.9e-05	0.000969	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TRIO—hematologic cancer	3.89e-05	0.000966	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CMA1—hematologic cancer	3.89e-05	0.000966	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TRH—hematologic cancer	3.89e-05	0.000966	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—UGT1A1—hematologic cancer	3.88e-05	0.000963	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SPHK1—hematologic cancer	3.8e-05	0.000945	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGO2—hematologic cancer	3.8e-05	0.000945	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CRABP1—hematologic cancer	3.77e-05	0.000937	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC22A1—hematologic cancer	3.77e-05	0.000937	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LPAR1—hematologic cancer	3.77e-05	0.000936	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HDAC9—hematologic cancer	3.77e-05	0.000936	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—H3F3B—hematologic cancer	3.73e-05	0.000926	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CD—hematologic cancer	3.7e-05	0.000919	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALOX5—hematologic cancer	3.68e-05	0.000913	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—hematologic cancer	3.65e-05	0.000907	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRB2—hematologic cancer	3.6e-05	0.000894	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NUP98—hematologic cancer	3.56e-05	0.000885	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CSF2—hematologic cancer	3.54e-05	0.000879	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3R1—hematologic cancer	3.49e-05	0.000868	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDE4B—hematologic cancer	3.47e-05	0.000861	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CNR2—hematologic cancer	3.47e-05	0.000861	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ADCY7—hematologic cancer	3.46e-05	0.000859	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA3—hematologic cancer	3.46e-05	0.000859	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF19—hematologic cancer	3.44e-05	0.000854	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NUP214—hematologic cancer	3.43e-05	0.000853	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—JAK1—hematologic cancer	3.42e-05	0.000849	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCG—hematologic cancer	3.42e-05	0.000849	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAC2—hematologic cancer	3.41e-05	0.000847	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—JAK2—hematologic cancer	3.39e-05	0.000843	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DKK1—hematologic cancer	3.38e-05	0.00084	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTR—hematologic cancer	3.36e-05	0.000835	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCG2—hematologic cancer	3.36e-05	0.000835	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT5B—hematologic cancer	3.36e-05	0.000834	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENO2—hematologic cancer	3.3e-05	0.000819	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADCY7—hematologic cancer	3.26e-05	0.00081	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CB—hematologic cancer	3.22e-05	0.000801	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CSF2—hematologic cancer	3.21e-05	0.000799	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—hematologic cancer	3.2e-05	0.000795	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2RA—hematologic cancer	3.19e-05	0.000793	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—XIAP—hematologic cancer	3.17e-05	0.000788	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SDC1—hematologic cancer	3.13e-05	0.000777	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCG—hematologic cancer	3.1e-05	0.000771	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—JAK1—hematologic cancer	3.1e-05	0.000771	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SH2B3—hematologic cancer	3.09e-05	0.000767	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SMARCA4—hematologic cancer	3.09e-05	0.000767	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GZMB—hematologic cancer	3.07e-05	0.000763	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CTNNA1—hematologic cancer	3e-05	0.000745	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HSPB1—hematologic cancer	2.98e-05	0.00074	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EIF4EBP1—hematologic cancer	2.98e-05	0.00074	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL3—hematologic cancer	2.98e-05	0.00074	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2—hematologic cancer	2.96e-05	0.000735	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTHLH—hematologic cancer	2.95e-05	0.000732	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SDC1—hematologic cancer	2.95e-05	0.000732	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2RA—hematologic cancer	2.9e-05	0.00072	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTGER4—hematologic cancer	2.87e-05	0.000713	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LCK—hematologic cancer	2.85e-05	0.000709	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—H3F3A—hematologic cancer	2.8e-05	0.000695	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCZ—hematologic cancer	2.72e-05	0.000676	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CG—hematologic cancer	2.66e-05	0.00066	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NQO1—hematologic cancer	2.66e-05	0.00066	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CD44—hematologic cancer	2.66e-05	0.00066	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EP300—hematologic cancer	2.66e-05	0.00066	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PARP1—hematologic cancer	2.63e-05	0.000653	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—HRAS—hematologic cancer	2.6e-05	0.000645	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FBXW7—hematologic cancer	2.58e-05	0.000642	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SRC—hematologic cancer	2.58e-05	0.000642	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HDAC2—hematologic cancer	2.53e-05	0.00063	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR4—hematologic cancer	2.53e-05	0.00063	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—hematologic cancer	2.52e-05	0.000625	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYCS—hematologic cancer	2.51e-05	0.000625	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSP90AA1—hematologic cancer	2.5e-05	0.000621	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NRAS—hematologic cancer	2.48e-05	0.000617	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CBL—hematologic cancer	2.47e-05	0.000614	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL3—hematologic cancer	2.44e-05	0.000607	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CG—hematologic cancer	2.41e-05	0.0006	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTPN1—hematologic cancer	2.4e-05	0.000597	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK3—hematologic cancer	2.38e-05	0.000591	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTPN11—hematologic cancer	2.37e-05	0.000589	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RASGRP1—hematologic cancer	2.36e-05	0.000587	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SYK—hematologic cancer	2.36e-05	0.000585	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HSP90AA1—hematologic cancer	2.36e-05	0.000585	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CD—hematologic cancer	2.34e-05	0.000581	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—hematologic cancer	2.31e-05	0.000574	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CREB1—hematologic cancer	2.3e-05	0.000571	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT1—hematologic cancer	2.27e-05	0.000564	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCL2—hematologic cancer	2.25e-05	0.000559	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6R—hematologic cancer	2.24e-05	0.000557	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—hematologic cancer	2.22e-05	0.000551	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3R1—hematologic cancer	2.21e-05	0.000548	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—JAK2—hematologic cancer	2.14e-05	0.000533	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KRAS—hematologic cancer	2.14e-05	0.000531	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAP2K1—hematologic cancer	2.14e-05	0.000531	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRB2—hematologic cancer	2.13e-05	0.000528	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CD—hematologic cancer	2.12e-05	0.000527	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFA—hematologic cancer	2.12e-05	0.000527	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCB1—hematologic cancer	2.1e-05	0.000521	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KITLG—hematologic cancer	2.09e-05	0.000519	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT5A—hematologic cancer	2.04e-05	0.000507	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOR1—hematologic cancer	2.04e-05	0.000506	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—hematologic cancer	2.04e-05	0.000506	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CB—hematologic cancer	2.04e-05	0.000506	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN2B—hematologic cancer	2.02e-05	0.000503	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3R1—hematologic cancer	2e-05	0.000498	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—hematologic cancer	1.96e-05	0.000488	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CD86—hematologic cancer	1.96e-05	0.000487	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—JAK2—hematologic cancer	1.95e-05	0.000484	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HES1—hematologic cancer	1.93e-05	0.00048	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NCOR1—hematologic cancer	1.92e-05	0.000477	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—hematologic cancer	1.9e-05	0.000472	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CSF2—hematologic cancer	1.9e-05	0.000472	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF1—hematologic cancer	1.9e-05	0.000472	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FOXO1—hematologic cancer	1.87e-05	0.000465	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2—hematologic cancer	1.87e-05	0.000465	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFRB—hematologic cancer	1.87e-05	0.000464	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CB—hematologic cancer	1.85e-05	0.00046	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFRA—hematologic cancer	1.84e-05	0.000457	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCG—hematologic cancer	1.83e-05	0.000455	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAK1—hematologic cancer	1.83e-05	0.000455	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HRAS—hematologic cancer	1.82e-05	0.000452	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—hematologic cancer	1.8e-05	0.000447	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2RA—hematologic cancer	1.71e-05	0.000425	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2—hematologic cancer	1.7e-05	0.000422	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TERT—hematologic cancer	1.69e-05	0.000421	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFB—hematologic cancer	1.65e-05	0.00041	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TSC2—hematologic cancer	1.61e-05	0.000401	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—hematologic cancer	1.6e-05	0.000399	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGFR3—hematologic cancer	1.55e-05	0.000386	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK14—hematologic cancer	1.54e-05	0.000382	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CG—hematologic cancer	1.51e-05	0.000376	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ESR1—hematologic cancer	1.51e-05	0.000375	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FN1—hematologic cancer	1.49e-05	0.00037	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BAD—hematologic cancer	1.47e-05	0.000366	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NFKBIA—hematologic cancer	1.47e-05	0.000366	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH1—hematologic cancer	1.46e-05	0.000362	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CD80—hematologic cancer	1.43e-05	0.000355	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KIT—hematologic cancer	1.43e-05	0.000354	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CG—hematologic cancer	1.43e-05	0.000354	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—NRAS—hematologic cancer	1.43e-05	0.000354	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CREBBP—hematologic cancer	1.4e-05	0.000348	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTPN11—hematologic cancer	1.4e-05	0.000348	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAPK3—hematologic cancer	1.37e-05	0.000339	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CREB1—hematologic cancer	1.36e-05	0.000337	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BRAF—hematologic cancer	1.34e-05	0.000333	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CD—hematologic cancer	1.33e-05	0.00033	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL2—hematologic cancer	1.33e-05	0.00033	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6R—hematologic cancer	1.32e-05	0.000329	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CREBBP—hematologic cancer	1.32e-05	0.000328	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—hematologic cancer	1.31e-05	0.000326	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAP2K1—hematologic cancer	1.26e-05	0.000314	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3R1—hematologic cancer	1.26e-05	0.000312	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CD—hematologic cancer	1.25e-05	0.000311	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.24e-05	0.000309	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KRAS—hematologic cancer	1.23e-05	0.000305	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF2—hematologic cancer	1.2e-05	0.000298	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3R1—hematologic cancer	1.18e-05	0.000294	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CB—hematologic cancer	1.16e-05	0.000288	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAK2—hematologic cancer	1.15e-05	0.000286	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—hematologic cancer	1.13e-05	0.00028	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MDM2—hematologic cancer	1.12e-05	0.000279	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MTOR—hematologic cancer	1.09e-05	0.000271	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CB—hematologic cancer	1.09e-05	0.000271	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HRAS—hematologic cancer	1.04e-05	0.000259	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1B—hematologic cancer	1.03e-05	0.000255	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—hematologic cancer	1.01e-05	0.000252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—hematologic cancer	1e-05	0.00025	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2—hematologic cancer	1e-05	0.000249	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTEN—hematologic cancer	1e-05	0.000249	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—hematologic cancer	9.98e-06	0.000248	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—hematologic cancer	9.78e-06	0.000243	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JUN—hematologic cancer	9.76e-06	0.000243	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—EP300—hematologic cancer	9.55e-06	0.000237	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1A—hematologic cancer	9.46e-06	0.000235	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTEN—hematologic cancer	9.44e-06	0.000235	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK8—hematologic cancer	9.24e-06	0.000229	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—hematologic cancer	9.21e-06	0.000229	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EP300—hematologic cancer	9e-06	0.000224	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SRC—hematologic cancer	8.76e-06	0.000218	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—hematologic cancer	8.53e-06	0.000212	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—hematologic cancer	8.44e-06	0.00021	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NRAS—hematologic cancer	8.42e-06	0.000209	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK3—hematologic cancer	8.07e-06	0.0002	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—hematologic cancer	7.85e-06	0.000195	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—hematologic cancer	7.83e-06	0.000194	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KRAS—hematologic cancer	7.25e-06	0.00018	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—hematologic cancer	7.06e-06	0.000176	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—hematologic cancer	6.66e-06	0.000165	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—hematologic cancer	6.44e-06	0.00016	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HRAS—hematologic cancer	6.16e-06	0.000153	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—hematologic cancer	5.9e-06	0.000147	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—hematologic cancer	5.77e-06	0.000143	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—hematologic cancer	5.44e-06	0.000135	CbGpPWpGaD
